Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9512446 Engineered CRISPR-Cas9 nucleases

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 4, 2016
Date of Patent
December 6, 2016
Patent Application Number
15015947
Patent Citations Received
‌
US Patent 12133884 Methods of substituting pathogenic amino acids using programmable base editor systems
0
‌
US Patent 12104207 Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-Seq)
0
‌
US Patent 12110545 Methods of assessing nuclease cleavage
0
‌
US Patent 12123032 CRISPR enzyme mutations reducing off-target effects
0
‌
US Patent 11661590 Programmable CAS9-recombinase fusion proteins and uses thereof
0
‌
US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing
0
‌
US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing
0
‌
US Patent 11697826 Nucleic acid-guided nucleases
0
‌
US Patent 11702651 Adenosine nucleobase editors and uses thereof
0
‌
US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9512446
Patent Primary Examiner
‌
Karen Cochrane Carlson

Find more entities like US Patent 9512446 Engineered CRISPR-Cas9 nucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo